a Genpact company  
Home > Corporate > Leadership Team > NV "Tiger" Tyagarajan

Leadership Team

EmPower Research provides a compelling business advantage.
- Bob Feldman, CEO & Managing Partner, Feldman & Partner

NV "Tiger" Tyagarajan

President & CEO, Genpact

Tiger is credited as one of the pioneers who transformed Genpact (formerly GE Capital International Services) into a high-end business process and technology management company. Today, Genpact is an acknowledged leader and serves its global customers from 50+ operations centers in 17 countries with over 53,000 employees. The company manages over 4,500 processes for more than 600 clients worldwide across the banking and finance, capital markets, insurance, manufacturing, healthcare, pharmaceuticals, consumer products, retail, transportation and business services sectors. Genpact is publicly listed on the New York Stock Exchange under the symbol ‘G’.

Tiger began his career with the Unilever Group in India where he spent seven years in sales and marketing and then three years with Citibank’s Consumer Financial Services businesses in business, sales, operations and credit. He joined GE Capital in 1994 as Head of Risk in India and went on to become CEO for GE Capital's Global Consumer Finance and Auto Financial Services operations in India.

In 1999 he became CEO of GE Capital International Services, significantly expanding its service offerings and operations. In 2002, he transferred within GE to the Global Commercial Lending Businesses in the U.S. as Global Head of Six Sigma and Global Operations.

Tiger rejoined Genpact in February 2005 as Executive Vice President, Sales, Marketing and M&A, was promoted to the position of Chief Operating Officer in 2009 and was named President and CEO in June 2011.

Tiger has a degree in mechanical engineering from the Indian Institute of Technology, Mumbai, and an MBA, majoring in Finance and Marketing, from the Indian Institute of Management, Ahmedabad.

Read Tiger's blog: Tiger Bytes

In the Spotlight

Social media applications across the drug life-cycle

Download Presentation
Debjani Deb and Vrinda Deval of EmPower Research talk about the opportunities social media provides to interact with patients and HCPs throughout the drug lifecycle

Watch Video

Blogs

by Arun Swamy
 

Join Our Mailing List

Listen. Learn. EmPower
EmPower Research on FacebookEmPower Research on LinkedInEmPower Research on TwitterNewSense - EmPower Research Corporate Blog